Two Years of Sarilumab in Patients with Rheumatoid Arthritis and an Inadequate Response to MTX: Safety, Efficacy and Radiographic Outcomes
Rheumatology 2018;57:1423–1431 DOI: 10.1093/rheumatology/key121
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Rheumatology 2018;57:1423–1431 DOI: 10.1093/rheumatology/key121
Exp Rev Clin Immunol 2018 Nov;14(11):945-956. DOI: 10.1080/1744666X.2018.1504678
Rheumatol Ther 2018 Jun; 5(1):283–91
Please click the links below to go to the CSF review of each paper.
Rheumatology (Oxford). 2018 Mar 1;57(3):499-507. DOI: 10.1093/rheumatology/kex443
J Rheumatol 2018 Apr; 45(4):456-464
Rheumatology (Oxford) 2017 Dec 1;56(12):2179-2189 doi: 10.1093/rheumatology/kex319
J Rheumatol 2018 Feb; 45(2):177-87
Nat Rev Drug Discov 2017;16:843–62 DOI: 10.1038/nrd.2017.201
J Rheumatol. 2018 Jan;45(1):14-21. doi: 10.3899/jrheum.161161